<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2017.4725</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-4725</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Allicin protects against H<sub>2</sub>O<sub>2</sub>-induced apoptosis of PC12 cells via the mitochondrial pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Lv</surname><given-names>Runxiao</given-names></name>
<xref rid="af1-etm-0-0-4725" ref-type="aff">1</xref>
<xref rid="fn1-etm-0-0-4725" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Du</surname><given-names>Lili</given-names></name>
<xref rid="af2-etm-0-0-4725" ref-type="aff">2</xref>
<xref rid="fn1-etm-0-0-4725" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Lu</surname><given-names>Chunwen</given-names></name>
<xref rid="af3-etm-0-0-4725" ref-type="aff">3</xref>
<xref rid="af4-etm-0-0-4725" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Jinhui</given-names></name>
<xref rid="af3-etm-0-0-4725" ref-type="aff">3</xref>
<xref rid="af4-etm-0-0-4725" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Ding</surname><given-names>Muchen</given-names></name>
<xref rid="af3-etm-0-0-4725" ref-type="aff">3</xref>
<xref rid="af4-etm-0-0-4725" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Chao</given-names></name>
<xref rid="af3-etm-0-0-4725" ref-type="aff">3</xref>
<xref rid="af4-etm-0-0-4725" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Mao</surname><given-names>Ningfang</given-names></name>
<xref rid="af3-etm-0-0-4725" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Shi</surname><given-names>Zhicai</given-names></name>
<xref rid="af3-etm-0-0-4725" ref-type="aff">3</xref>
<xref rid="c1-etm-0-0-4725" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-4725"><label>1</label>Department of Rehabilitation Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China</aff>
<aff id="af2-etm-0-0-4725"><label>2</label>Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, Liaoning 110122, P.R. China</aff>
<aff id="af3-etm-0-0-4725"><label>3</label>Department of Orthopedics, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China</aff>
<aff id="af4-etm-0-0-4725"><label>4</label>Graduate Management Unit, The Second Military Medical University, Shanghai 200433, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-4725"><italic>Correspondence to</italic>: Dr Zhicai Shi, Department of Orthopedics, Changhai Hospital, The Second Military Medical University, 168 Changhai Road, Shanghai 200433, P.R. China, E-mail: <email>zhicai_shizc@163.com</email></corresp>
<fn id="fn1-etm-0-0-4725"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>09</month>
<year>2017</year></pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>07</month>
<year>2017</year></pub-date>
<volume>14</volume>
<issue>3</issue>
<fpage>2053</fpage>
<lpage>2059</lpage>
<history>
<date date-type="received"><day>29</day><month>01</month><year>2016</year></date>
<date date-type="accepted"><day>26</day><month>01</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Lv et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Allicin is a major bioactive ingredient of garlic and has a broad range of biological activities. Allicin has been reported to protect against cell apoptosis induced by H<sub>2</sub>O<sub>2</sub> in human umbilical vein endothelial cells. The present study evaluated the neuroprotective effect of allicin on the H<sub>2</sub>O<sub>2</sub>-induced apoptosis of rat pheochromocytoma PC12 cells <italic>in vitro</italic> and explored the underlying mechanism involved. PC12 cells were incubated with increasing concentrations of allicin and the toxic effect of allicin was measured by MTT assay. The cells were pretreated for 24 h with low dose (L-), medium dose (M-) and high dose (H-) of allicin, followed by exposure to 200 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 2 h, and the cell viability was examined by MTT assay. In addition, cell apoptosis rate was analyzed by Annexin V-FITC/PI assay, while intracellular reactive oxygen species (ROS) and mitochondrial transmembrane potential (&#x2206;&#x03C8;m) were measured by flow cytometry. Bcl-2, Bax, cleaved-caspase-3 and cytochrome <italic>c</italic> (Cyt C) in the mitochondria were also examined by western blotting. The results demonstrated that 0.01 &#x00B5;g/ml (L-allicin), 0.1 &#x00B5;g/ml (M-allicin) and 1 &#x00B5;g/ml (H-allicin) were non-toxic doses of allicin. Furthermore, H<sub>2</sub>O<sub>2</sub> reduced cell viability, promoted cell apoptosis, induced ROS production and decreased &#x2206;&#x03C8;m. However, allicin treatment reversed the effect of H<sub>2</sub>O<sub>2</sub> in a dose-dependent manner. It was also observed that H<sub>2</sub>O<sub>2</sub> exposure significantly decreased Bcl-2 and mitochondrial Cyt C, while it increased Bax and cleaved-caspase-3, which were attenuated by allicin pretreatment. The results revealed that allicin protected PC12 cells from H<sub>2</sub>O<sub>2</sub>-induced cell apoptosis via the mitochondrial pathway, suggesting the potential neuroprotective effect of allicin against neurological diseases.</p>
</abstract>
<kwd-group>
<kwd>allicin</kwd>
<kwd>H<sub>2</sub>O<sub>2</sub></kwd>
<kwd>PC12 cells</kwd>
<kwd>neuroprotection</kwd>
<kwd>apoptosis</kwd>
<kwd>mitochondrial pathway</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Neurological diseases, including Parkinson&#x0027;s, Huntington&#x0027;s and Alzheimer&#x0027;s disease, as well as traumatic brain injury and stroke, are the leading cause of mortality worldwide (<xref rid="b1-etm-0-0-4725" ref-type="bibr">1</xref>). Oxidative stress, defined as an imbalance between antioxidants and prooxidants, serves a major role in numerous biological events. The cells of the central nervous system are highly sensitive to injuries induced by oxidative stress (<xref rid="b2-etm-0-0-4725" ref-type="bibr">2</xref>). Increasing evidence has revealed that apoptosis, inflammation and oxidative stress are correlated with these neurological diseases (<xref rid="b3-etm-0-0-4725" ref-type="bibr">3</xref>&#x2013;<xref rid="b5-etm-0-0-4725" ref-type="bibr">5</xref>). Reactive oxygen species (ROS), including hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), hydroxyl radical (HO.) and superoxide radical (O<sub>2</sub><sup>&#x2212;</sup>), are byproducts of cellular processes and are primarily generated in the mitochondrion of the cells (<xref rid="b6-etm-0-0-4725" ref-type="bibr">6</xref>,<xref rid="b7-etm-0-0-4725" ref-type="bibr">7</xref>). Approximately 1&#x2013;2&#x0025; of the mitochondrial oxygen consumption is used to produce ROS (<xref rid="b8-etm-0-0-4725" ref-type="bibr">8</xref>). ROS are reported to serve a critical role in the release of pro-apoptotic proteins and cytochrome <italic>c</italic> (Cyt C), which activate caspase family members and induce cell apoptosis (<xref rid="b9-etm-0-0-4725" ref-type="bibr">9</xref>). Therefore, inhibiting oxidative stress-induced neuronal injury is considered as a therapeutic strategy in the treatment of neurological diseases (<xref rid="b10-etm-0-0-4725" ref-type="bibr">10</xref>).</p>
<p>Garlic possesses various biological properties, such as immunomodulatory, anticancer, antiaging, antimicrobial, antihypertensive and antiatherosclerotic effects (<xref rid="b11-etm-0-0-4725" ref-type="bibr">11</xref>&#x2013;<xref rid="b14-etm-0-0-4725" ref-type="bibr">14</xref>). These properties are closely correlated with the bioactive ingredients of garlic (<xref rid="b15-etm-0-0-4725" ref-type="bibr">15</xref>). Allicin is the main compound extracted from garlic and has strong antioxidant activity (<xref rid="b16-etm-0-0-4725" ref-type="bibr">16</xref>,<xref rid="b17-etm-0-0-4725" ref-type="bibr">17</xref>). Chen <italic>et al</italic> have demonstrated that allicin protects human umbilical vein endothelial cells (HUVECs) from H<sub>2</sub>O<sub>2</sub>-induced cell apoptosis by inhibiting oxidative stress (<xref rid="b18-etm-0-0-4725" ref-type="bibr">18</xref>).</p>
<p>In the present study, H<sub>2</sub>O<sub>2</sub> was used to establish an <italic>in vitro</italic> model of oxidative stress injury, and the intervention effect of allicin on the apoptosis of rat pheochromocytoma PC12 cells was evaluated. To the best of our knowledge, this is the first to evaluate the effect of allicin on H<sub>2</sub>O<sub>2</sub>-induced apoptosis of PC12 cells <italic>in vitro</italic>.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<p>Cell culture. Rat pheochromocytoma PC12 cells were obtained from the Cell Bank at the Chinese Academy of Sciences (Shanghai, China). PC12 cells were maintained in RPMI 1640 medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10&#x0025; fetal bovine serum (FBS; GE Healthcare Life Sciences, South Logan, Utah, USA). The cells were cultured in a 5&#x0025; CO<sub>2</sub> incubator at 37&#x00B0;C.</p>
<sec>
<title/>
<sec>
<title>Cytotoxicity of allicin</title>
<p>PC12 cells were cultured in 96-well plates (6&#x00D7;103 cells/well) for 24 h and incubated with increasing concentrations of allicin (0, 0.01, 0.1, 1, 10, 100 or 1,000 &#x00B5;g/ml; Yuanye Bio-Technology Co., Ltd., Shanghai, China) for a further 24 h. MTT (5 mg/ml, 20 &#x00B5;l; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was added into each well and cultured at 37&#x00B0;C for 4 h to produce formazan crystals. After discarding the medium, the cells were treated with dimethyl sulfoxide (Sigma-Aldrich), and the absorbance was analyzed at 490 nm (BioTek Instruments, Inc., Winooski, VT, USA). Concentrations of allicin found to be non-toxic were selected for subsequent experiments.</p>
</sec>
<sec>
<title>Cell treatment</title>
<p>After culturing for 24 h, PC12 cells were pretreated with 0.01 (low dose, L-allicin), 0.1 (medium dose, M-allicin) or 1 &#x00B5;g/ml (high dose, H-allicin) of allicin for 24 h and then exposed to 200 &#x00B5;M hydrogen peroxide (H<sub>2</sub>O<sub>2;</sub> Xilong Chemical Co., Ltd., Shenyang, China) for 2 h. Cells incubated only with 200 &#x00B5;M H<sub>2</sub>O<sub>2</sub> for 2 h served as the H<sub>2</sub>O<sub>2</sub> group, while untreated cells served as the control.</p>
</sec>
<sec>
<title>Cell viability</title>
<p>Subsequent to incubation with H<sub>2</sub>O<sub>2</sub> and allicin, the cell viability was determined by MTT (Sigma-Aldrich; Merck KGaA) assay as previously described (<xref rid="b19-etm-0-0-4725" ref-type="bibr">19</xref>). The absorbance of cells was detected with a microplate reader (BioTek Instruments, Inc.) at 490 nm.</p>
</sec>
<sec>
<title>Cell apoptosis</title>
<p>AnnexinV-FITC/propidium iodide (PI) assay (catalogue no. WLA001b; Wanleibio, Shenyang, China) was performed to analyze cell apoptosis. Briefly, PC12 cells were washed with phosphate-buffered saline (PBS; Shanghai Double-helic Biology Science and Technology Co., Ltd., Shanghai, China) and resuspended in binding buffer (500 &#x00B5;l), followed by incubation with Annexin V-FITC (5 &#x00B5;l) and PI (5 &#x00B5;l) in the dark. After washing twice with PBS, the cells were collected and cell apoptosis was analyzed by a BD Accuri&#x2122; C6 flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). LL represents survival cells (Annexin V-/PI-). LR represents early apoptotic cells (Annexin V&#x002B;/PI-). UR represents late apoptotic or necrotic cells (Annexin V&#x002B;/PI&#x002B;). UL represents dead cells (Annexin V-/PI&#x002B;). The total apoptotic cell rate was calculated as follows: Early apoptotic cell rate &#x002B; late apoptotic cell rate.</p>
</sec>
<sec>
<title>Measurement of ROS level</title>
<p>Intercellular ROS level was measured according to the protocol of the Reactive Oxygen Species Assay kit (catalogue no. S0033; Beyotime Institute of Biotechnology, Haimen, China). Briefly, DCFH-DA (10 mM) supplied in the kit was diluted to 10 &#x00B5;M with serum-free medium. Subsequent to the indicated allicin and H<sub>2</sub>O<sub>2</sub> treatment, the medium was discarded, and PC12 cells were incubated with the diluted DCFH-DA (2 ml) at 37&#x00B0;C for 20 min and washed three times with serum-free medium. Subsequently, the cells were washed twice with PBS and detected by flow cytometry (BD Biosciences) to determine the ROS levels.</p>
</sec>
<sec>
<title>Measurement of mitochondrial transmembrane potential (&#x2206;&#x03C8;m)</title>
<p>The &#x2206;&#x03C8;m was determined using a JC-1 Apoptosis Detection kit (catalogue no. KGA601; KeyGen Biotech Co., Ltd., Nanjing, China) according to the manufacturer&#x0027;s instructions. Briefly, the cells were collected following the indicated treatment and resuspended in 500 &#x00B5;l incubation buffer containing 1 &#x00B5;l JC-1 at 37&#x00B0;C for 20 min. Subsequent to centrifugation (550 &#x00D7; g for 5 min at room temperature), the cells were washed and resuspended in 1X incubation buffer (KeyGen Biotech Co., Ltd.). The cells were then subjected to flow cytometry (BD Biosciences) in order to determine the &#x2206;&#x03C8;m. UR represents normal cells. LR represents early apoptotic cells.</p>
</sec>
<sec>
<title>Western blotting</title>
<p>The cells were cultured in 6-well plates at a density of 4&#x00D7;105 cells/well prior to being lysed in lysis buffer (Wanleibio) on ice and total proteins were obtained by centrifugation (10,005 &#x00D7; g for 10 min at 4&#x00B0;C). The cells were homogenized and mitochondrial proteins were isolated using a Mitochondrial Protein Extraction kit (catalogue no. WLA034; Wanleibio) according to the manufacturer&#x0027;s instructions. Protein concentration was measured using a BCA kit (catalogue no. WLA004; Wanleibio). Subsequently, 40 &#x00B5;g protein was separated by 7, 10 or 12&#x0025; SDS-PAGE and transferred onto polyvinylidene fluoride membranes (EMD Millipore, Bedford, MA, USA). After blocking with non-fat milk for 1 h, the membranes were incubated with polyclonal antibodies against Bcl-2 (WL01556; 1:500 dilution; Wanleibio), Bax (WL01637; 1:500 dilution; Wanleibio), cleaved-caspase3 (WL01992; 1:500 dilution; Wanleibio), Cyt C (WL01571; 1:500 dilution; Wanleibio), COX IV (WL01794; 1:500 dilution; Wanleibio) and &#x03B2;-actin (WL01845; 1:1,000 dilution; Wanleibio). &#x03B2;-actin and COX IV served as the internal controls for total proteins and mitochondrial proteins, respectively. Subsequently, cells were incubated with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (WLA023; 1:5,000 dilution; Wanleibio). The protein bands were visualized using an enhanced chemiluminescence reagent (Wanleibio) and quantified with Gel-Pro-Analyzer version 4.0 software (Media Cybernetics, Bethesda, MD, USA).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Results are expressed as the mean &#x00B1; standard deviation. Statistical analysis was performed by Student&#x0027;s t test or one-way analysis of variance followed by Bonferroni&#x0027;s multiple comparison test using GraphPad Prism 5 (GraphPad Software, Inc., San Diego, CA, USA). Differences with a P&#x003C;0.05 were considered as statistically significant.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Selection of the non-toxic concentrations of allicin</title>
<p>The cytotoxicity of various concentrations allicin was determined by MTT assay. As shown in <xref rid="f1-etm-0-0-4725" ref-type="fig">Fig. 1</xref>, the allicin doses of 10 (P&#x003C;0.05), 100 (P&#x003C;0.01) and 1,000 &#x00B5;g/ml (P&#x003C;0.01) significantly decreased the viability of PC12 cells compared with the untreated cells. However, the other three concentrations of allicin (0.01, 0.1 and 1 &#x00B5;g/ml) did not markedly affect the cell viability. Therefore, these three doses were named as the low (L-allicin; 0.01 &#x00B5;g/ml), medium (M-allicin; 0.1 &#x00B5;g/ml) and high dose groups (H-allicin; 1 &#x00B5;g/ml).</p>
</sec>
<sec>
<title>Allicin attenuates H<sub>2</sub>O<sub>2</sub>-induced cell growth inhibition</title>
<p>To assess the protective effect of allicin on the cell proliferation of PC12 cells, the cells were pretreated with L-allicin, M-allicin or H-allicin for 24 h and then incubated with H<sub>2</sub>O<sub>2</sub>. Cell viability was determined by MTT assay. As shown in <xref rid="f2-etm-0-0-4725" ref-type="fig">Fig. 2</xref>, H<sub>2</sub>O<sub>2</sub> (200 &#x00B5;M) significantly impaired the cell viability of PC12 cells (P&#x003C;0.01). However, allicin treatment markedly improved the decreased cell viability caused by H<sub>2</sub>O<sub>2</sub> in a dose-dependent manner, with the medium and high doses having a significant effect (both P&#x003C;0.01).</p>
</sec>
<sec>
<title>Allicin protects PC12 cells against H<sub>2</sub>O<sub>2</sub>-induced cell apoptosis</title>
<p>Annexin V-FITC/PI assay was performed to evaluate the effect of allicin on H<sub>2</sub>O<sub>2</sub>-induced cell apoptosis. As shown in <xref rid="f3-etm-0-0-4725" ref-type="fig">Fig. 3</xref>, incubation with H<sub>2</sub>O<sub>2</sub> significantly increased the apoptosis rate to 24.43&#x00B1;2.07&#x0025; compared with the control group (2.94&#x00B1;0.45&#x0025;; P&#x003C;0.01). However, allicin treatment significantly lowered the apoptosis rate in the L-allicin, M-allicin and H-allicin groups to 18.72&#x00B1;2.50, 6.87&#x00B1;1.03 and 6.15&#x00B1;0.47&#x0025;, respectively, compared with the rate in the H<sub>2</sub>O<sub>2</sub> group (P&#x003C;0.05, P&#x003C;0.01 and P&#x003C;0.01, respectively).</p>
</sec>
<sec>
<title>Allicin restores ROS level and &#x2206;&#x03C8;m in H<sub>2</sub>O<sub>2</sub>-treated PC12 cells</title>
<p>The study further evaluated the effect of allicin on H<sub>2</sub>O<sub>2</sub>-induced ROS generation using DCFH-DA (<xref rid="f4-etm-0-0-4725" ref-type="fig">Fig. 4A-E</xref>). The intracellular ROS levels in the control and H<sub>2</sub>O<sub>2</sub>-treated cells were 8.27&#x00B1;1.26 and 34.39&#x00B1;2.77&#x0025;, respectively. By contrast, the ROS levels in the allicin-treated cells were 28.03&#x00B1;2.70, 17.73&#x00B1;1.86 and 11.11&#x00B1;1.68&#x0025;, respectively. These results showed that H<sub>2</sub>O<sub>2</sub> treatment significantly elevated the intracellular ROS level (P&#x003C;0.01; <xref rid="f4-etm-0-0-4725" ref-type="fig">Fig. 4F</xref>). Notably, pretreatment with allicin inhibited H<sub>2</sub>O<sub>2</sub>-induced ROS production in a dose-dependent manner (L-allicin, P&#x003C;0.05; M-allicin, P&#x003C;0.01; H-allicin, P&#x003C;0.01).</p>
<p>In order to determine the &#x2206;&#x03C8;m, PC12 cells were stimulated with H<sub>2</sub>O<sub>2</sub> for 2 h and then stained with JC-1 prior to flow cytometric analysis (<xref rid="f5-etm-0-0-4725" ref-type="fig">Fig. 5A-E</xref>). The results demonstrated that H<sub>2</sub>O<sub>2</sub> exposure resulted in the loss of &#x2206;&#x03C8;m compared with the control group (P&#x003C;0.01; <xref rid="f5-etm-0-0-4725" ref-type="fig">Fig. 5F</xref>). However, allicin prevented the loss of &#x2206;&#x03C8;m in H2O2-stimulated PC12 cells in a dose-dependent manner (M-allicin, P&#x003C;0.01; H-allicin, P&#x003C;0.01).</p>
</sec>
<sec>
<title>Effect of allicin on the expression of Bcl-2, Bax, cleaved-caspase-3 and mitochondrial Cyt C</title>
<p>The levels of Bcl-2, Bax, cleaved-caspase-3 and mitochondrial Cyt C were examined by western blotting subsequent to allicin and H<sub>2</sub>O<sub>2</sub> treatment. As shown in <xref rid="f6-etm-0-0-4725" ref-type="fig">Fig. 6</xref>, H<sub>2</sub>O<sub>2</sub> exposure greatly decreased Bcl-2 and mitochondrial Cyt C levels, whereas it increased Bax and cleaved-caspase-3 levels when compared with the control group (P&#x003C;0.01). Allicin pretreatment reversed the effect of H<sub>2</sub>O<sub>2</sub> on the expression of Bcl-2 (M-allicin, P&#x003C;0.05; H-allicin, P&#x003C;0.01), Bax (H-allicin, P&#x003C;0.01), cleaved-caspase-3 (M-allicin, P&#x003C;0.05; H-allicin, P&#x003C;0.01) and mitochondrial Cyt C (H-allicin, P&#x003C;0.01).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Allicin, an active compound extracted from garlic, has antitumor, anti-inflammatory, anti-oxidative and anti-microbial activities (<xref rid="b20-etm-0-0-4725" ref-type="bibr">20</xref>,<xref rid="b21-etm-0-0-4725" ref-type="bibr">21</xref>). Oxidative stress serves a vital role in the neurodegeneration process, and H<sub>2</sub>O<sub>2</sub> has been reported to be an inductor of ROS release, which contributes to the occurrence and progression of neurodegenerative diseases (<xref rid="b22-etm-0-0-4725" ref-type="bibr">22</xref>). Previous studies have observed that allicin exerts neuroprotective effects against traumatic brain injury <italic>in vitro</italic> and <italic>in vivo</italic> via the Akt/eNOS signaling pathway due to its anti-oxidative and anti-inflammatory activities (<xref rid="b23-etm-0-0-4725" ref-type="bibr">23</xref>,<xref rid="b24-etm-0-0-4725" ref-type="bibr">24</xref>). In addition, allicin administration alleviates learning and memory impairment in a mice model of Alzheimer&#x0027;s disease by inhibiting the p38 MAPK pathway (<xref rid="b25-etm-0-0-4725" ref-type="bibr">25</xref>).</p>
<p>To the best of our knowledge, the present study was the first to evaluate the neuroprotective effect of allicin in H<sub>2</sub>O<sub>2</sub>-stimulated rat pheochromocytoma PC12 cells. The effect of increasing concentrations of allicin on PC12 cell viability was evaluated, and three relative low concentrations of allicin (0.01, 0.1 and 1 &#x00B5;g/ml) were selected for further experiments. Next, the neuroprotective effect of allicin on cell viability, apoptosis, ROS generation, &#x2206;&#x03C8;m and the mitochondrial intrinsic pathway were further evaluated in H<sub>2</sub>O<sub>2</sub>-treated PC12 cells.</p>
<p>H<sub>2</sub>O<sub>2</sub> treatment has been commonly used as a method to evaluate antioxidant efficiency or oxidative stress susceptibility of cells that are susceptible to oxidative injury (<xref rid="b26-etm-0-0-4725" ref-type="bibr">26</xref>). In the present study, we established an <italic>in vitro</italic> model of H<sub>2</sub>O<sub>2</sub>-induced oxidative injury in PC12 cells. It was observed that H<sub>2</sub>O<sub>2</sub> promoted PC12 cell apoptosis, increased intracellular ROS levels, reduced &#x2206;&#x03C8;m, decreased mitochondrial Cyt C levels and Bcl-2 levels, and elevated Bax and cleaved-caspase-3 levels. These findings were in agreement with previous reports (<xref rid="b27-etm-0-0-4725" ref-type="bibr">27</xref>,<xref rid="b28-etm-0-0-4725" ref-type="bibr">28</xref>).</p>
<p>The degeneration of neurons in the brain or spinal cord is associated with neurodegenerative disease (<xref rid="b29-etm-0-0-4725" ref-type="bibr">29</xref>). In the present study, the effect of allicin on cell viability in the present of H<sub>2</sub>O<sub>2</sub> was firstly investigated. It was demonstrated that allicin attenuated the inhibitory effect of H<sub>2</sub>O<sub>2</sub> on cell proliferation in a dose-dependent manner. Apoptosis is a process of programmed cell death that is regulated by the extrinsic pathway and the intrinsic pathway (<xref rid="b30-etm-0-0-4725" ref-type="bibr">30</xref>). It has been reported that allicin suppressed the apoptosis of rat H9c2 cells and HUVECs induced by H<sub>2</sub>O<sub>2</sub> (<xref rid="b18-etm-0-0-4725" ref-type="bibr">18</xref>,<xref rid="b31-etm-0-0-4725" ref-type="bibr">31</xref>). In the present study, the results of Annexin V-FITC/PI assay showed that H<sub>2</sub>O<sub>2</sub> markedly promoted PC12 cell apoptosis, which was inhibited by allicin pretreatment in a dose-dependent manner. These findings indicate that allicin protected H<sub>2</sub>O<sub>2</sub>-treated PC12 cells by increasing cell viability and inhibiting cell apoptosis.</p>
<p>ROS functions in multiple intracellular signaling pathways as a secondary messenger and serves as a mediator in inflammation and oxidative injury (<xref rid="b2-etm-0-0-4725" ref-type="bibr">2</xref>). Mitochondria are the major ROS-producing organelle and the target of ROS (<xref rid="b32-etm-0-0-4725" ref-type="bibr">32</xref>). Apoptosis signals initially lead to the enhancement of mitochondrial permeability and the loss of &#x2206;&#x03C8;m. Cyt C is then translocated into the cytosol and caspase-3/9 is activated to induce cell apoptosis (<xref rid="b33-etm-0-0-4725" ref-type="bibr">33</xref>,<xref rid="b34-etm-0-0-4725" ref-type="bibr">34</xref>). The depolarization of &#x2206;&#x03C8;m, mitochondria swelling, the increase of malondialdehyde and ROS, and the decrease of superoxide dismutase are the characteristics of mitochondrial dysfunction (<xref rid="b35-etm-0-0-4725" ref-type="bibr">35</xref>). Zhu <italic>et al</italic> have demonstrated that allicin provides protection against spinal cord ischemia/reperfusion injury in rabbits through enhancing antioxidant enzyme activities and improving mitochondrial function (<xref rid="b36-etm-0-0-4725" ref-type="bibr">36</xref>). Furthermore, allicin alleviated H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity in retinal pigmented epithelial cells by reducing ROS and oxidative stress (<xref rid="b37-etm-0-0-4725" ref-type="bibr">37</xref>). The current study results consistently demonstrated that allicin ameliorated H<sub>2</sub>O<sub>2</sub>-induced ROS generation and the collapse of &#x2206;&#x03C8;m in rat pheochromocytoma PC12 cells. The results indicate that allicin protected against H<sub>2</sub>O<sub>2</sub>-induced apoptosis by inhibiting the dysfunction of mitochondria.</p>
<p>The expression of Bcl-2 family members, Bcl-2 (an anti-apoptotic protein) and Bax (a pro-apoptotic protein), are known to be associated with the apoptotic process. In addition, the imbalance between Bcl-2 and Bax results in the release of Cyt C from the mitochondria, which in turn activates the downstream caspases (<xref rid="b38-etm-0-0-4725" ref-type="bibr">38</xref>,<xref rid="b39-etm-0-0-4725" ref-type="bibr">39</xref>). Caspases include various cysteine proteases that are responsible for cell apoptosis in eukaryotes (<xref rid="b40-etm-0-0-4725" ref-type="bibr">40</xref>). Caspase-3, also known as a molecular switch, belongs to the cysteine protease family and degrades downstream substrates during apoptosis (<xref rid="b41-etm-0-0-4725" ref-type="bibr">41</xref>). The results of the present study demonstrated that allicin reversed the effect of H<sub>2</sub>O<sub>2</sub> on the expression of Bcl-2, Bax, cleaved-caspase-3 and mitochondrial Cyt C in PC12 cells (<xref rid="b18-etm-0-0-4725" ref-type="bibr">18</xref>), suggesting the involvement of the mitochondrial pathway in the neuroprotection of PC12 cells.</p>
<p>In conclusion, allicin protected PC12 cells against H<sub>2</sub>O<sub>2</sub>-induced oxidative injury via the mitochondrial pathway. The present study provides evidence for the clinical application of allicin as a candidate anti-oxidative drug for neuroprotection.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-4725"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Niu</surname><given-names>H</given-names></name><name><surname>Shao</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Dixon</surname><given-names>BJ</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Astaxanthin as a potential neuroprotective agent for neurological diseases</article-title><source>Mar Drugs</source><volume>13</volume><fpage>5750</fpage><lpage>5766</lpage><year>2015</year><pub-id pub-id-type="doi">10.3390/md13095750</pub-id><pub-id pub-id-type="pmid">26378548</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-4725"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naseem</surname><given-names>M</given-names></name><name><surname>Parvez</surname><given-names>S</given-names></name></person-group><article-title>Role of melatonin in traumatic brain injury and spinal cord injury</article-title><source>ScientificWorldJournal</source><volume>2014</volume><fpage>586270</fpage><year>2014</year><pub-id pub-id-type="doi">10.1155/2014/586270</pub-id><pub-id pub-id-type="pmid">25587567</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-4725"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bossy-Wetzel</surname><given-names>E</given-names></name><name><surname>Schwarzenbacher</surname><given-names>R</given-names></name><name><surname>Lipton</surname><given-names>SA</given-names></name></person-group><article-title>Molecular pathways to neurodegeneration</article-title><source>Nat Med</source><volume>10</volume><comment>(Suppl)</comment><fpage>S2</fpage><lpage>S9</lpage><year>2004</year><pub-id pub-id-type="doi">10.1038/nm1067</pub-id><pub-id pub-id-type="pmid">15272266</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-4725"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bramlett</surname><given-names>HM</given-names></name><name><surname>Dietrich</surname><given-names>WD</given-names></name></person-group><article-title>Pathophysiology of cerebral ischemia and brain trauma: Similarities and differences</article-title><source>J Cereb Blood Flow Metab</source><volume>24</volume><fpage>133</fpage><lpage>150</lpage><year>2004</year><pub-id pub-id-type="doi">10.1097/01.WCB.0000111614.19196.04</pub-id><pub-id pub-id-type="pmid">14747740</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-4725"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnham</surname><given-names>KJ</given-names></name><name><surname>Masters</surname><given-names>CL</given-names></name><name><surname>Bush</surname><given-names>AI</given-names></name></person-group><article-title>Neurodegenerative diseases and oxidative stress</article-title><source>Nat Rev Drug Discov</source><volume>3</volume><fpage>205</fpage><lpage>214</lpage><year>2004</year><pub-id pub-id-type="doi">10.1038/nrd1330</pub-id><pub-id pub-id-type="pmid">15031734</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-4725"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widlansky</surname><given-names>ME</given-names></name><name><surname>Gutterman</surname><given-names>DD</given-names></name></person-group><article-title>Regulation of endothelial function by mitochondrial reactive oxygen species</article-title><source>Antioxid Redox Signal</source><volume>15</volume><fpage>1517</fpage><lpage>1530</lpage><year>2011</year><pub-id pub-id-type="doi">10.1089/ars.2010.3642</pub-id><pub-id pub-id-type="pmid">21194353</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-4725"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>QJ</given-names></name><name><surname>Gao</surname><given-names>XM</given-names></name><name><surname>Ma</surname><given-names>YT</given-names></name><name><surname>Chen</surname><given-names>BD</given-names></name><name><surname>Yu</surname><given-names>ZX</given-names></name><name><surname>Li</surname><given-names>XM</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>YN</given-names></name></person-group><article-title>Inhibition of the NF-&#x03BA;B pathway by R65 ribozyme gene via adeno-associatedvirus serotype 9 ameliorated oxidized LDL induced human umbilical vein endothelial cell injury</article-title><source>Int J Clin Exp Pathol</source><volume>8</volume><fpage>9912</fpage><lpage>9921</lpage><year>2015</year><pub-id pub-id-type="pmid">26617700</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-4725"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadenas</surname><given-names>E</given-names></name><name><surname>Davies</surname><given-names>KJ</given-names></name></person-group><article-title>Mitochondrial free radical generation, oxidative stress, and aging</article-title><source>Free Radic Biol Med</source><volume>29</volume><fpage>222</fpage><lpage>230</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0891-5849(00)00317-8</pub-id><pub-id pub-id-type="pmid">11035250</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-4725"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname><given-names>M</given-names></name><name><surname>Gogvadze</surname><given-names>V</given-names></name><name><surname>Orrenius</surname><given-names>S</given-names></name><name><surname>Zhivotovsky</surname><given-names>B</given-names></name></person-group><article-title>Mitochondria, oxidative stress and cell death</article-title><source>Apoptosis</source><volume>12</volume><fpage>913</fpage><lpage>922</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/s10495-007-0756-2</pub-id><pub-id pub-id-type="pmid">17453160</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-4725"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Huo</surname><given-names>T</given-names></name></person-group><article-title>SOD2 mediates amifostine-induced protection against glutamate in PC12 cells</article-title><source>Oxid Med Cell Longev</source><volume>2016</volume><fpage>4202437</fpage><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/4202437</pub-id><pub-id pub-id-type="pmid">26770652</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-4725"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovesn&#x00E1;</surname><given-names>J</given-names></name><name><surname>Mitrov&#x00E1;</surname><given-names>K</given-names></name><name><surname>Ku&#x010D;era</surname><given-names>L</given-names></name></person-group><article-title>Garlic (<italic>A. sativum</italic> L.) alliinase gene family polymorphism reflects bolting types and cysteine sulphoxides content</article-title><source>BMC Genet</source><volume>16</volume><fpage>53</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12863-015-0214-z</pub-id><pub-id pub-id-type="pmid">25997498</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-4725"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatua</surname><given-names>TN</given-names></name><name><surname>Adela</surname><given-names>R</given-names></name><name><surname>Banerjee</surname><given-names>SK</given-names></name></person-group><article-title>Garlic and cardioprotection: Insights into the molecular mechanisms</article-title><source>Can J Physiol Pharmacol</source><volume>91</volume><fpage>448</fpage><lpage>458</lpage><year>2013</year><pub-id pub-id-type="doi">10.1139/cjpp-2012-0315</pub-id><pub-id pub-id-type="pmid">23746107</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-4725"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amagase</surname><given-names>H</given-names></name><name><surname>Petesch</surname><given-names>BL</given-names></name><name><surname>Matsuura</surname><given-names>H</given-names></name><name><surname>Kasuga</surname><given-names>S</given-names></name><name><surname>Itakura</surname><given-names>Y</given-names></name></person-group><article-title>Intake of garlic and its bioactive components</article-title><source>J Nutr</source><volume>131</volume><issue>3s</issue><fpage>955S</fpage><lpage>962S</lpage><year>2001</year><pub-id pub-id-type="pmid">11238796</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-4725"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>J</given-names></name><name><surname>Harfouche</surname><given-names>Y</given-names></name><name><surname>De La Cruz</surname><given-names>M</given-names></name><name><surname>Zamora</surname><given-names>MP</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Rego</surname><given-names>JA</given-names></name><name><surname>Buckley</surname><given-names>NE</given-names></name></person-group><article-title>Garlic (<italic>Allium sativum</italic>) stimulates lipopolysaccharide-induced tumor necrosis factor-alpha production from J774A.1 murine macrophages</article-title><source>Phytother Res</source><volume>29</volume><fpage>288</fpage><lpage>294</lpage><year>2015</year><pub-id pub-id-type="doi">10.1002/ptr.5253</pub-id><pub-id pub-id-type="pmid">25366263</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-4725"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name></person-group><article-title>Fresh garlic extract enhances the antimicrobial activities of antibiotics on resistant strains in Vitro</article-title><source>Jundishapur J Microbiol</source><volume>8</volume><fpage>e14814</fpage><year>2015</year><pub-id pub-id-type="doi">10.5812/jjm.14814</pub-id><pub-id pub-id-type="pmid">26060559</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-4725"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Mao</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>CH</given-names></name></person-group><article-title>Allicin Protects PC12 Cells Against 6-OHDA-Induced Oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics</article-title><source>Cell Physiol Biochem</source><volume>36</volume><fpage>966</fpage><lpage>979</lpage><year>2015</year><pub-id pub-id-type="doi">10.1159/000430271</pub-id><pub-id pub-id-type="pmid">26087780</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-4725"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name></person-group><article-title>Allicin protects against myocardial apoptosis and fibrosis in streptozotocin-induced diabetic rats</article-title><source>Phytomedicine</source><volume>19</volume><fpage>693</fpage><lpage>698</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.phymed.2012.04.007</pub-id><pub-id pub-id-type="pmid">22633288</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-4725"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Wo</surname><given-names>L</given-names></name><name><surname>Chai</surname><given-names>H</given-names></name></person-group><article-title>Allicin prevents H<sub>2</sub>O<sub>2</sub>-induced apoptosis of HUVECs by inhibiting an oxidative stress pathway</article-title><source>BMC Complement Altern Med</source><volume>14</volume><fpage>321</fpage><year>2014</year><pub-id pub-id-type="doi">10.1186/1472-6882-14-321</pub-id><pub-id pub-id-type="pmid">25174844</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-4725"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XP</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>CB</given-names></name><name><surname>Zheng</surname><given-names>YT</given-names></name><name><surname>He</surname><given-names>XS</given-names></name><name><surname>Yuan</surname><given-names>XP</given-names></name></person-group><article-title>MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway</article-title><source>Oncotarget</source><volume>8</volume><fpage>13264</fpage><lpage>13276</lpage><year>2017</year><pub-id pub-id-type="pmid">28129650</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-4725"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Kashef</surname><given-names>DH</given-names></name><name><surname>El-Kenawi</surname><given-names>AE</given-names></name><name><surname>Suddek</surname><given-names>GM</given-names></name><name><surname>Salem</surname><given-names>HA</given-names></name></person-group><article-title>Protective effect of allicin against gentamicin-induced nephrotoxicity in rats</article-title><source>Int Immunopharmacol</source><volume>29</volume><fpage>679</fpage><lpage>686</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.intimp.2015.09.010</pub-id><pub-id pub-id-type="pmid">26391062</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-4725"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Lun</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Lei</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Zhi</surname><given-names>F</given-names></name></person-group><article-title>Allicin alleviates inflammation of trinitrobenzenesulfonic acid-induced rats and suppresses P38 and JNK pathways in Caco-2 cells</article-title><source>Mediators Inflamm</source><volume>2015</volume><fpage>434692</fpage><year>2015</year><pub-id pub-id-type="doi">10.1155/2015/434692</pub-id><pub-id pub-id-type="pmid">25729217</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-4725"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhuna</surname><given-names>K</given-names></name><name><surname>Dhuna</surname><given-names>V</given-names></name><name><surname>Bhatia</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Kamboj</surname><given-names>SS</given-names></name></person-group><article-title>Cytoprotective effect of methanolic extract of Nardostachys jatamansi against hydrogen peroxide induced oxidative damage in C6 glioma cells</article-title><source>Acta Biochim Pol</source><volume>60</volume><fpage>21</fpage><lpage>31</lpage><year>2013</year><pub-id pub-id-type="pmid">23513188</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-4725"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>MD</given-names></name><name><surname>Bao</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Xiang</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>WF</given-names></name></person-group><article-title>Neuroprotective effect of allicin against traumatic brain injury via Akt/endothelial nitric oxide synthase pathway-mediated anti-inflammatory and anti-oxidative activities</article-title><source>Neurochem Int</source><volume>68</volume><fpage>28</fpage><lpage>37</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.neuint.2014.08.003</pub-id><pub-id pub-id-type="pmid">24530793</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-4725"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>YF</given-names></name><name><surname>Li</surname><given-names>WT</given-names></name><name><surname>Han</surname><given-names>HC</given-names></name><name><surname>Gao</surname><given-names>DK</given-names></name><name><surname>He</surname><given-names>XS</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>JN</given-names></name><name><surname>Fei</surname><given-names>Z</given-names></name></person-group><article-title>Allicin protects rat cortical neurons against mechanical trauma injury by regulating nitric oxide synthase pathways</article-title><source>Brain Res Bull</source><volume>100</volume><fpage>14</fpage><lpage>21</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.brainresbull.2013.10.013</pub-id><pub-id pub-id-type="pmid">24184006</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-4725"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XH</given-names></name><name><surname>Li</surname><given-names>CY</given-names></name><name><surname>Xiang</surname><given-names>ZG</given-names></name><name><surname>Zhong</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>ZY</given-names></name><name><surname>Lu</surname><given-names>JM</given-names></name></person-group><article-title>Allicin can reduce neuronal death and ameliorate the spatial memory impairment in Alzheimer&#x0027;s disease models</article-title><source>Neurosciences (Riyadh)</source><volume>15</volume><fpage>237</fpage><lpage>243</lpage><year>2010</year><pub-id pub-id-type="pmid">20956919</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-4725"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iloki-Assanga</surname><given-names>SB</given-names></name><name><surname>Lewis-Luj&#x00E1;n</surname><given-names>LM</given-names></name><name><surname>Fern&#x00E1;ndez-Angulo</surname><given-names>D</given-names></name><name><surname>Gil-Salido</surname><given-names>AA</given-names></name><name><surname>Lara-Espinoza</surname><given-names>CL</given-names></name><name><surname>Rubio-Pino</surname><given-names>JL</given-names></name></person-group><article-title>Retino-protective effect of Bucida buceras against oxidative stress induced by H2O2 in human retinal pigment epithelial cells line</article-title><source>BMC Complement Altern Med</source><volume>15</volume><fpage>254</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12906-015-0765-6</pub-id><pub-id pub-id-type="pmid">26219933</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-4725"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Tian</surname><given-names>XH</given-names></name><name><surname>Yi</surname><given-names>YS</given-names></name><name><surname>Jiang</surname><given-names>WS</given-names></name><name><surname>Zhou</surname><given-names>YJ</given-names></name><name><surname>Cheng</surname><given-names>WJ</given-names></name></person-group><article-title>Luteolin-induced protection of H<sub>2</sub>O<sub>2</sub>-induced apoptosis in PC12 cells and the associated pathway</article-title><source>Mol Med Rep</source><volume>12</volume><fpage>7699</fpage><lpage>7704</lpage><year>2015</year><pub-id pub-id-type="pmid">26459830</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-4725"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonafede</surname><given-names>R</given-names></name><name><surname>Scambi</surname><given-names>I</given-names></name><name><surname>Peroni</surname><given-names>D</given-names></name><name><surname>Potrich</surname><given-names>V</given-names></name><name><surname>Boschi</surname><given-names>F</given-names></name><name><surname>Benati</surname><given-names>D</given-names></name><name><surname>Bonetti</surname><given-names>B</given-names></name><name><surname>Mariotti</surname><given-names>R</given-names></name></person-group><article-title>Exosome derived from murine adipose-derived stromal cells: Neuroprotective effect on in vitro model of amyotrophic lateral sclerosis</article-title><source>Exp Cell Res</source><volume>340</volume><fpage>150</fpage><lpage>158</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.yexcr.2015.12.009</pub-id><pub-id pub-id-type="pmid">26708289</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-4725"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>Shamsuzzama L</given-names></name><name><surname>Haque</surname><given-names>R</given-names></name><name><surname>Nazir</surname><given-names>A</given-names></name></person-group><article-title>Role of MicroRNA Let-7 in modulating multifactorial aspect of neurodegenerative diseases: An overview</article-title><source>Mol Neurobiol</source><volume>53</volume><fpage>2787</fpage><lpage>2793</lpage><year>2016</year><pub-id pub-id-type="doi">10.1007/s12035-015-9145-y</pub-id><pub-id pub-id-type="pmid">25823513</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-4725"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanowicz-Hajduk</surname><given-names>J</given-names></name><name><surname>Bartoszewski</surname><given-names>R</given-names></name><name><surname>Bartoszewska</surname><given-names>S</given-names></name><name><surname>Kochan</surname><given-names>K</given-names></name><name><surname>Adamska</surname><given-names>A</given-names></name><name><surname>Kosi&#x0144;ski</surname><given-names>I</given-names></name><name><surname>Ochocka</surname><given-names>JR</given-names></name></person-group><article-title>Pennogenyl saponins from Paris quadrifolia L. induce extrinsic and intrinsic pathway of apoptosis in human cervical cancer HeLa cells</article-title><source>PLoS One</source><volume>10</volume><fpage>e0135993</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0135993</pub-id><pub-id pub-id-type="pmid">26295969</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-4725"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>JY</given-names></name><name><surname>Tsui</surname><given-names>HT</given-names></name><name><surname>Chung</surname><given-names>IY</given-names></name><name><surname>Chan</surname><given-names>RY</given-names></name><name><surname>Kwan</surname><given-names>YW</given-names></name><name><surname>Chan</surname><given-names>SW</given-names></name></person-group><article-title>Allicin protects rat cardiomyoblasts (H9c2 cells) from hydrogen peroxide-induced oxidative injury through inhibiting the generation of intracellular reactive oxygen species</article-title><source>Int J Food Sci Nutr</source><volume>65</volume><fpage>868</fpage><lpage>873</lpage><year>2014</year><pub-id pub-id-type="doi">10.3109/09637486.2014.925428</pub-id><pub-id pub-id-type="pmid">24945597</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-4725"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orrenius</surname><given-names>S</given-names></name><name><surname>Gogvadze</surname><given-names>V</given-names></name><name><surname>Zhivotovsky</surname><given-names>B</given-names></name></person-group><article-title>Mitochondrial oxidative stress: Implications for cell death</article-title><source>Annu Rev Pharmacol Toxicol</source><volume>47</volume><fpage>143</fpage><lpage>183</lpage><year>2007</year><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.47.120505.105122</pub-id><pub-id pub-id-type="pmid">17029566</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-4725"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bak</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>HD</given-names></name><name><surname>Kim</surname><given-names>YO</given-names></name><name><surname>Park</surname><given-names>CG</given-names></name><name><surname>Han</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>JJ</given-names></name></person-group><article-title>Neuroprotective effects of 20(S)-protopanaxadiol against glutamate-induced mitochondrial dysfunction in PC12 cells</article-title><source>Int J Mol Med</source><volume>37</volume><fpage>378</fpage><lpage>386</lpage><year>2016</year><pub-id pub-id-type="pmid">26709399</pub-id></element-citation></ref>
<ref id="b34-etm-0-0-4725"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halestrap</surname><given-names>AP</given-names></name><name><surname>Doran</surname><given-names>E</given-names></name><name><surname>Gillespie</surname><given-names>JP</given-names></name><name><surname>O&#x0027;Toole</surname><given-names>A</given-names></name></person-group><article-title>Mitochondria and cell death</article-title><source>Biochem Soc Trans</source><volume>28</volume><fpage>170</fpage><lpage>177</lpage><year>2000</year><pub-id pub-id-type="doi">10.1042/bst0280170</pub-id><pub-id pub-id-type="pmid">10816121</pub-id></element-citation></ref>
<ref id="b35-etm-0-0-4725"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name></person-group><article-title>Protective effects of salidroside on mitochondrial functions against exertional heat stroke-induced organ damage in the rat</article-title><source>Evid Based Complement Alternat Med</source><volume>2015</volume><fpage>504567</fpage><year>2015</year><pub-id pub-id-type="doi">10.1155/2015/504567</pub-id><pub-id pub-id-type="pmid">26664452</pub-id></element-citation></ref>
<ref id="b36-etm-0-0-4725"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>JW</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>WB</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Neuroprotective effects of allicin on spinal cord ischemia-reperfusion injury via improvement of mitochondrial function in rabbits</article-title><source>Neurochem Int</source><volume>61</volume><fpage>640</fpage><lpage>648</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.neuint.2012.06.021</pub-id><pub-id pub-id-type="pmid">22750272</pub-id></element-citation></ref>
<ref id="b37-etm-0-0-4725"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>YF</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name></person-group><article-title>Allicin attenuates H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity in retinal pigmented epithelial cells by regulating the levels of reactive oxygen species</article-title><source>Mol Med Rep</source><volume>13</volume><fpage>2320</fpage><lpage>2326</lpage><year>2016</year><pub-id pub-id-type="pmid">26781848</pub-id></element-citation></ref>
<ref id="b38-etm-0-0-4725"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Tong</surname><given-names>W</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name></person-group><article-title>Tanshinone IIA blocks dexamethasone-induced apoptosis in osteoblasts through inhibiting Nox4-derived ROS production</article-title><source>Int J Clin Exp Pathol</source><volume>8</volume><fpage>13695</fpage><lpage>13706</lpage><year>2015</year><pub-id pub-id-type="pmid">26722597</pub-id></element-citation></ref>
<ref id="b39-etm-0-0-4725"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>YB</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name></person-group><article-title>In vitro analysis of the role of the mitochondrial apoptosis pathway in CSBE therapy against human gastric cancer</article-title><source>Exp Ther Med</source><volume>10</volume><fpage>2403</fpage><lpage>2409</lpage><year>2015</year><pub-id pub-id-type="pmid">26668648</pub-id></element-citation></ref>
<ref id="b40-etm-0-0-4725"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lenardo</surname><given-names>MJ</given-names></name></person-group><article-title>Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies</article-title><source>J Cell Sci</source><volume>113</volume><fpage>753</fpage><lpage>757</lpage><year>2000</year><pub-id pub-id-type="pmid">10671365</pub-id></element-citation></ref>
<ref id="b41-etm-0-0-4725"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Geng</surname><given-names>L</given-names></name></person-group><article-title>Caspase-3 inhibitor prevents the apoptosis of brain tissue in rats with acute cerebral infarction</article-title><source>Exp Ther Med</source><volume>10</volume><fpage>133</fpage><lpage>138</lpage><year>2015</year><pub-id pub-id-type="pmid">26170924</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-4725" position="float">
<label>Figure 1.</label>
<caption><p>Cytotoxicity of various concentrations of allicin (0, 0.01, 0.1, 1, 10, 100 or 1,000 &#x00B5;g/ml) in PC12 cells incubated for 24 h. Cell viability was examined by MTT assay. &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. the control group.</p></caption>
<graphic xlink:href="etm-14-03-2053-g00.tif"/>
</fig>
<fig id="f2-etm-0-0-4725" position="float">
<label>Figure 2.</label>
<caption><p>Effect of allicin on cell viability. PC12 cells were pretreated with L-allicin (0.01 &#x00B5;g/ml), M-allicin (0.1 &#x00B5;g/ml) and H-allicin (1 &#x00B5;g/ml) for 24 h and then exposed to H<sub>2</sub>O<sub>2</sub> for 2 h. MTT assay was conducted to determine the cell viability. &#x002A;&#x002A;P&#x003C;0.01 vs. the control group; <sup>##</sup>P&#x003C;0.01 vs. the H<sub>2</sub>O<sub>2</sub> group.</p></caption>
<graphic xlink:href="etm-14-03-2053-g01.tif"/>
</fig>
<fig id="f3-etm-0-0-4725" position="float">
<label>Figure 3.</label>
<caption><p>Effect of allicin on cell apoptosis. Following treatment with allicin and H<sub>2</sub>O<sub>2</sub>, cell apoptosis was analyzed by Annexin V-FITC/propidium iodide staining. Flow cytometry findings of (A) control, (B) H<sub>2</sub>O<sub>2</sub>, (C) H<sub>2</sub>O<sub>2</sub>&#x002B;L-allicin, (D) H<sub>2</sub>O<sub>2</sub>&#x002B;M-allicin and (E) H<sub>2</sub>O<sub>2</sub>&#x002B;H-allicin are presented. (F) Quantified results of apoptosis rate. &#x002A;&#x002A;P&#x003C;0.01 vs. the control group; <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. the H<sub>2</sub>O<sub>2</sub> group. L-allicin, 0.01 &#x00B5;g/ml; M-allicin, 0.1 &#x00B5;g/ml; H-allicin, 1 &#x00B5;g/ml.</p></caption>
<graphic xlink:href="etm-14-03-2053-g02.tif"/>
</fig>
<fig id="f4-etm-0-0-4725" position="float">
<label>Figure 4.</label>
<caption><p>Effect of allicin on H<sub>2</sub>O<sub>2</sub>-induced ROS generation. PC12 cells were pretreated with allicin for 24 h, followed by exposure to H<sub>2</sub>O<sub>2</sub> for 2 h. The ROS levels were measured using DCFH-DA and flow cytometry. Flow cytometry findings of (A) control, (B) H<sub>2</sub>O<sub>2</sub>, (C) H<sub>2</sub>O<sub>2</sub>&#x002B;L-allicin, (D) H<sub>2</sub>O<sub>2</sub>&#x002B;M-allicin and (E) H<sub>2</sub>O<sub>2</sub>&#x002B;H-allicin are presented. (F) Quantified results of ROS generation. &#x002A;&#x002A;P&#x003C;0.01 vs. the control group; <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. the H<sub>2</sub>O<sub>2</sub> group. L-allicin, 0.01 &#x00B5;g/ml; M-allicin, 0.1 &#x00B5;g/ml; H-allicin, 1 &#x00B5;g/ml; ROS, reactive oxygen species.</p></caption>
<graphic xlink:href="etm-14-03-2053-g03.tif"/>
</fig>
<fig id="f5-etm-0-0-4725" position="float">
<label>Figure 5.</label>
<caption><p>Effect of allicin on &#x2206;&#x03C8;m. After 24-h incubation in 6-well plate, the cells were subjected to H<sub>2</sub>O<sub>2</sub> and allicin treatment. The &#x2206;&#x03C8;m of PC12 cells was analyzed by flow cytometry. Flow cytometry findings of (A) control, (B) H<sub>2</sub>O<sub>2</sub>, (C) H<sub>2</sub>O<sub>2</sub>&#x002B;L-allicin, (D) H<sub>2</sub>O<sub>2</sub>&#x002B;M-allicin, and (E) H<sub>2</sub>O<sub>2</sub>&#x002B;H-allicin are presented. (F) Quantified results of &#x2206;&#x03C8;m. &#x002A;&#x002A;P&#x003C;0.01 vs. the control group; <sup>##</sup>P&#x003C;0.01 vs. the H<sub>2</sub>O<sub>2</sub> group. L-allicin, 0.01 &#x00B5;g/ml; M-allicin, 0.1 &#x00B5;g/ml; H-allicin, 1 &#x00B5;g/ml; &#x2206;&#x03C8;m, mitochondrial transmembrane potential.</p></caption>
<graphic xlink:href="etm-14-03-2053-g04.tif"/>
</fig>
<fig id="f6-etm-0-0-4725" position="float">
<label>Figure 6.</label>
<caption><p>Effect of allicin on the expression of various mitochondrial pathway regulators. Subsequent to treatment, total proteins and mitochondrial proteins were extracted from the PC12 cells. The levels of Bax, Bcl-2, cleaved-caspase-3 and Cyt C in the mitochondria were quantified by western blot analysis. &#x03B2;-actin and COX IV served as the internal controls for total proteins and mitochondrial proteins, respectively. &#x002A;&#x002A;P&#x003C;0.01 vs. the control group; <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. the H<sub>2</sub>O<sub>2</sub> group. L-allicin, 0.01 &#x00B5;g/ml; M-allicin, 0.1 &#x00B5;g/ml; H-allicin, 1 &#x00B5;g/ml; Cyt C, cytochrome <italic>c</italic>.</p></caption>
<graphic xlink:href="etm-14-03-2053-g05.tif"/>
</fig>
</floats-group>
</article>
